Mice were injected with Lewis lung carcinoma or B16 melanoma cells and a control group was compared to genetically modified groups with adipose triglyceride lipase (ATGL) or hormone-sensitive lipase (HSL) deficiency. The gene discussed is PNPLA2; the disease is melanoma.